Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 2/20 | 0.75 |
| ▸ | BACE1 | P56817 | 2/20 | 0.75 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.75 |
| ▸ | TYR | P14679 | 3/20 | 0.73 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.73 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.73 |
| ▸ | CA12 | O43570 | 3/20 | 0.73 |
| ▸ | CA7 | P43166 | 3/20 | 0.73 |
| ▸ | CA9 | Q16790 | 3/20 | 0.73 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.73 |
| ▸ | PKM | P14618 | 2/20 | 0.73 |
| ▸ | CA1 | P00915 | 2/20 | 0.73 |
| ▸ | CA2 | P00918 | 2/20 | 0.73 |
| ▸ | CA4 | P22748 | 2/20 | 0.73 |
| ▸ | CA6 | P23280 | 2/20 | 0.73 |
| ▸ | CA5A | P35218 | 2/20 | 0.73 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.73 |
| ▸ | ESR1 | P03372 | 1/20 | 0.73 |
| ▸ | CA3 | P07451 | 1/20 | 0.73 |
| ▸ | DPP4 | P27487 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3825974 | 1.00 | GSK3B (0.75) | GSK3BBACE1TLR9TYRAKR1B10 | |
| SCHEMBL3825969 | 1.00 | GSK3B (0.75) | GSK3BBACE1TLR9TYRAKR1B10 | |
| SCHEMBL609968 | 0.86 | GSK3B (1.00) | GSK3BBACE1TLR9TYRAKR1B10 | |
| SCHEMBL609967 | 0.86 | GSK3B (1.00) | GSK3BBACE1TLR9TYRAKR1B10 | |
| Coumaric Acid SCHEMBL6333097 | 0.85 | ESR1 (1.00) | GSK3BBACE1TLR9TYRAKR1B10 | |
| Coumaric Acid SCHEMBL6333102 | 0.85 | ESR1 (1.00) | GSK3BBACE1TLR9TYRAKR1B10 | |
| Coumaric Acid SCHEMBL434720 | 0.85 | ESR1 (1.00) | GSK3BBACE1TLR9TYRAKR1B10 | |
| Coumaric Acid SCHEMBL20702657 | 0.85 | ESR1 (1.00) | GSK3BBACE1TLR9TYRAKR1B10 | |
| Coumaric Acid SCHEMBL43601 | 0.85 | ESR1 (1.00) | GSK3BBACE1TLR9TYRAKR1B10 | |
| Coumaric Acid SCHEMBL39106 | 0.85 | ESR1 (1.00) | GSK3BBACE1TLR9TYRAKR1B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8710038-B2 | Pyrazole kinase modulators and methods of use | EXELIXIS, INC. (US) | 2014-04-29 | — | — | US | disclosed |
| EP-1797072-A4 | PYRAZOLE KINASE MODULATORS AND METHODS OF USE | EXELIXIS INC (US) | 2009-09-09 | — | — | EP | disclosed |
| US-20070293507-A1 | Pyrazole Kinase Modulators And Methods Of Use | EXELIXIS, INC. (US) | 2007-12-20 | — | — | US | disclosed |
| EP-1797072-A2 | PYRAZOLE KINASE MODULATORS AND METHODS OF USE | Exelixis, Inc. (US) | 2007-06-20 | — | — | EP | disclosed |
| WO-2006033943-A2 | PYRAZOLE KINASE MODULATORS AND METHODS OF USE | EXELIXIS, INC (US) | 2006-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070293507-A1 | Pyrazole Kinase Modulators And Methods Of Use | MAP3K1, MAP3K3, MAP3K5 | GSK3B 169/4885BACE1 1551/4885TLR9 3829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.